We have observed
7 EP applications
Alison Lesley Lee
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
BCMA (CD269/TNFRSF17) -BINDING PROTEINS
ANTI LRP6 ANTIBODIES
TNF-ALPHA ANTIGEN-BINDING PROTEINS
LIQUID FORMULATION COMPRISING ADALIMUMAB AND AN ACETATE BUFFER
CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE
DOSING REGIMEN OF COMBINATION OF ANTI-CD20 AND ANTI-BLYS ANTIBODIES